Company Selected - Takeda Pharmaceutical Co. Ltd. - Cashflow Statement
| Fiscal Year is From April To March - All Figures are in JPY, Thousands | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | View Chart |
|---|---|---|---|---|---|
Hid Net Income | 33,075,000 | 136,923,000 | 107,928,000 | 208,065,000 | |
Hid Depreciation | 743,342,000 | 750,812,000 | 761,396,000 | 758,371,000 | |
| 71,189,000 | 74,012,000 | 72,867,000 | 73,428,000 | ||
| 154,253,000 | 118,835,000 | 162,648,000 | 122,230,000 | ||
Hid [-] Change In Working Capital | 102,769,000 | 379,000 | -69,479,000 | -45,347,000 | |
HidHid Change Receivables | 46,903,000.00 | 36,868,000 | -58,959,000 | 28,792,000 | |
HidHid Change To Inventory | -25,786,000 | -37,963,000 | -34,973,000 | -17,234,000 | |
HidHid Change To Liabilities | - | - | - | - | |
| - | - | - | - | ||
| 21,550,000 | -74,012,000 | -72,867,000 | -73,428,000 | ||
| 1,126,178,000 | 1,006,949,000 | 962,493,000 | 1,043,319,000 | ||
| -194,619,000 | -191,267,000 | -200,795,000 | -196,538,000 | ||
Hid Investments | -216,562,000 | -243,560,000 | -367,060,000 | -408,863,000 | |
| 127,804,000.00 | 172,409,000 | 182,500,000 | 167,034,000 | ||
| -182,419,000.00 | -262,418,000 | -385,355,000 | -438,367,000 | ||
Hid Net Borrowings | -593,474,000.00 | -650,562,000 | -498,480,000 | -314,112,000 | |
| -101,581,000 | -101,581,000 | -51,860,000 | -1,882,000 | ||
Hid Dividends Paid | -309,271,000 | -309,683,000 | -302,498,000 | -301,886,000 | |
| -89,744,000.00 | -106,670,000 | 214,397,000 | 209,820,000 | ||
| -1,097,263,000 | -1,168,496,000 | -638,441,000 | -408,060,000 | ||
| 350,008,000 | 233,742,000 | 494,126,000 | 859,015,000 | ||
| - | - | - | - | ||
Hid Change In Cash | 318,114,000 | 116,266,000 | -260,384,000 | -364,889,000 | |
| 681,486,000 | 350,008,000 | 233,742,000 | 494,126,000 | ||
| 1,035,909,969 | 920,634,195 | 854,244,156 | 942,347,236 | ||
| 12,682,000.00 | 165,120,000 | 263,218,000 | 532,669,000 |